Li D, Zhou W, Pang J, Tang Q, Zhong B, Shen C
Vella and Malaguarnera, 2018
GIP receptor activation enhances insulin secretion, improves fat metabolism, and may contribute to central nervous system effects on appetite that go beyond what GLP-1 alone can achieve
Future Microbiol
Virta is a metabolic-disease and type-2-diabetes-reversal program that prescribes GLP-1 medications when clinically appropriate the actual prescribing decision is deferred to a 20-minute live video visit with an Enrollment Nurse, scheduled at the end of the funnel
Increasing access will require addressing the significant barriers to care, such as treatment cost, site of care, and the policies that insurance plans can implement, such as step therapy and prior authorizations. For the study, the team used national insurance claims data for more than 97,000 commercially insured US adults diagnosed with obesity, but not diabetes, between June 2021 and July 2022